The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lloyd George W. since 2020.
This trader's CIK number is 1814899.
At the time of last reporting, Lloyd George W. was the EVP, Investments & CLO of Royalty Pharma Plc. (stock ticker symbol RPRX).
Also see all insider trading activities at Royalty Pharma Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RPRX | 0 | $0 | 330,000 | $11,584,610 | 0 | $0 |
| 2022 | RPRX | 0 | $0 | 300,000 | $12,399,532 | 0 | $0 |
| 2021 | RPRX | 0 | $0 | 940,178 | $41,851,101 | 0 | $0 |
| 2020 | RPRX | 14,200 | $397,600 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-06 | RPRX | Sale | 79,099 | 33.82 | 2,674,811 |
| 2023-06-02 | RPRX | Sale | 93,907 | 33.59 | 3,154,430 |
| 2023-06-05 | RPRX | Sale | 19,215 | 33.54 | 644,451 |
| 2023-03-28 | RPRX | Sale | 100,000 | 37.06 | 3,706,100 |
| 2023-03-29 | RPRX | Sale | 12,779 | 37.03 | 473,168 |
| 2023-02-23 | RPRX | Sale | 25,000 | 37.27 | 931,650 |
| 2022-08-09 | RPRX | Sale | 11,859 | 43.92 | 520,799 |
| 2022-08-10 | RPRX | Sale | 8,995 | 43.92 | 395,105 |
| 2022-07-28 | RPRX | Sale | 4,046 | 43.97 | 177,894 |
| 2022-07-25 | RPRX | Sale | 30,671 | 42.94 | 1,317,012 |
| 2022-07-26 | RPRX | Sale | 19,329 | 43.08 | 832,654 |
| 2022-07-27 | RPRX | Sale | 25,100 | 43.83 | 1,100,158 |
| 2022-05-26 | RPRX | Sale | 86,026 | 40.21 | 3,459,363 |
| 2022-05-27 | RPRX | Sale | 13,974 | 40.77 | 569,747 |
| 2022-05-23 | RPRX | Sale | 100,000 | 40.27 | 4,026,800 |
| 2021-11-16 | RPRX | Sale | 165,852 | 42.55 | 7,056,173 |
| 2021-11-17 | RPRX | Sale | 84,148 | 42.39 | 3,566,865 |
| 2021-07-26 | RPRX | Sale | 13,362 | 39.79 | 531,620 |
| 2021-07-12 | RPRX | Sale | 100 | 42.04 | 4,204 |
| 2021-07-13 | RPRX | Sale | 23,049 | 42.01 | 968,242 |
| 2021-07-06 | RPRX | Sale | 36,530 | 42.41 | 1,549,273 |
| 2021-07-07 | RPRX | Sale | 2,900 | 42.01 | 121,834 |
| 2021-07-08 | RPRX | Sale | 49,059 | 42.05 | 2,062,832 |
| 2021-06-10 | RPRX | Sale | 70,000 | 46.48 | 3,253,250 |
| 2021-06-08 | RPRX | Sale | 70,000 | 46.48 | 3,253,460 |
| 2021-06-07 | RPRX | Sale | 122,500 | 46.34 | 5,676,160 |
| 2021-06-04 | RPRX | Sale | 60,000 | 44.78 | 2,686,920 |
| 2021-06-02 | RPRX | Sale | 62,500 | 42.11 | 2,631,812 |
| 2021-04-12 | RPRX | Sale | 449 | 42.32 | 19,001 |
| 2021-03-22 | RPRX | Sale | 54,729 | 46.56 | 2,548,455 |
| 2021-03-02 | RPRX | Sale | 125,000 | 47.37 | 5,921,000 |
| 2020-06-18 | RPRX | Buy | 14,200 | 28.00 | 397,600 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lloyd George W. (EVP, Investments & CLO of Royalty Pharma Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.